Treatment of chronic hepatitis C in children with pegylated interferon α2a and ribavirin - A multi-center study

Acta Poloniae Pharmaceutica - Drug Research

Volumn 69, Issue 2, 2012, Pages 319-326

  Słuzewski, Wojciech ^a   Kowala Piaskowska, Arleta ^a   Wysocki, Jacek ^a   Figlerowicz, Magdalena ^a   Gorczyca, Anna ^b   Halota, Waldemar ^c   Jóźwiak, Hanna ^d   Mizerski, Jacek ^b   Mozer Lisewska, Iwona ^a   Pawłowska, Małgorzata ^c   Rokitka, Maria ^b   Strawińska, Elzbieta ^e   Szamotulska, Katarzyna ^f  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

^c NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^d Specialistic Regional Center for Mother and Child Health Care   (Poland)

^e Voivodship Hospital for Infectious Deseases and Observation   (Poland)

^f INSTITUTE OF MOTHER AND CHILD   (Poland)

Author keywords

Chronic hepatitis C; Combined therapy in children with CHC; Pegylated interferon; Sustained virological response

Indexed keywords

ALANINE AMINOTRANSFERASE; PEGINTERFERON ALPHA2A; RIBAVIRIN; ALPHA INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; RECOMBINANT PROTEIN;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGGRESSION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANTIVIRAL ACTIVITY; APPETITE DISORDER; ARTICLE; ASTHENIA; CHEMICAL PARAMETERS; CHILD; CLINICAL ARTICLE; CLINICAL SKIN REACTION; DISEASE CLASSIFICATION; DRUG SAFETY; ENTEROCOLITIS; FEMALE; FEVER; FLU LIKE SYNDROME; GENOTYPE; HAIR LOSS; HASHIMOTO DISEASE; HEPATITIS C; HUMAN; HYPERTHERMIA; INJECTION SITE PAIN; IRRITABILITY; LEUKOPENIA; LIVER FIBROSIS; MALE; MYALGIA; NAUSEA; NEUTROPENIA; PHARYNGITIS; POLAND; PRESCHOOL CHILD; PROGNOSIS; SCHOOL CHILD; SIDE EFFECT; SOMNOLENCE; THROMBOCYTOPENIA; THYROTROPIN BLOOD LEVEL; TONSIL DISEASE; VIRUS INFECTION; VIRUS LOAD; WEAKNESS; WEIGHT REDUCTION; CLINICAL TRIAL; DRUG COMBINATION; MULTICENTER STUDY;

ADOLESCENT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; RIBAVIRIN; VIRAL LOAD;

EID: 84861666962     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Wills R.J: Clin. Pharmacokinet. 19, 390 (1990).
2. Wang Y.S., Youngster S., Grace M., Bausch J., Bordens R., Wyss D.F: Adv. Drug Deliv. Rev. 54, 547 (2002).
3. Crotty S., Maag D., Arnold J.J. et al.: Nat. Med. 6, 1375 (2000).
4. Służewski W., Figlerowicz M., Mozer-Lisewska I.: Ped. Prakt. 9, 47 (2001) (Polish).
5. Wirth S., Lang T., Gehring S., Gerner P.: Hepatology 36, 1280 (2002).
6. Woźniakowska-Gȩsicka T., Kupś J., Kubacki J.: Pediatr. Pol. 11, 961 (2003) (Polish).
7. Gonzalez-Peralta R.P., Kelly D.A., Haber B. et al.: Hepatology 42, 1010 (2005).
8. Carithers R.L. Jr., Emerson S.S.: Hepatology 26, 83 (1997).
9. Cianciara J., Hryniewicz H., Stańczak W. et al.: Hepatol. Pol. 4, 147 (1997) (Polish).
10. Thevenot T., Regimbeau C., Ratziu V., Leroy V., Opolon P., Poynard T.: J. Viral. Hepat. 8, 48 (2001).
11. Myers R.P., Poynard T: Cochrane Database Syst. Rev. (4), CD003617 (2002).
12. Crotty S., Cameron C.E., Andino R.: Proc. Natl. Acad. Sci. USA 98, 6895 (2001).
13. Manns M.P., McHutchison J.G., Gordon S.C. et al.: Lancet 358, 958 (2001).
14. Fried M.W., Shiffman M.L., Reddy K.R. et al.: N. Engl. J. Med. 347: 975 (2002).
15. Juszczyk J., Białkowska J., Bolewska B. et al.: Pol. Merkur. Lekarski 94, 353 (2004) (Polish).
16. Kowala-Piaskowska A., Służewski W., Figlerowicz M., Mozer-Lisewska I.: Pediatr. Pol. 79, 878 (2004) (Polish).
17. Kowala-Piaskowska A., Figlerowicz M., Mozer-Lisewska I., Służewski W.: Przegl. Epidemiol. 59, 491 (2005) (Polish).
18. Kowala-Piaskowska A., Służewski W., Figlerowicz M., Mozer-Lisewska I.: Hepatol. Res. 32, 224 (2005).
19. Wirth S., Pieper-Boustani H., Lang T., Ballauff A., Kullmer U., Gerner P., Wintermeyer P., Jenke A.: Hepatology 41, 1013 (2005).
20. Garcia-Monzon C., Jara P., Fernandez-Bermejo M. et al.: Hepatology 28, 1696 (1998).
21. Davis G.L., Wong J.B., McHutchison J.G. et al.: Hepatology 38, 645 (2003).
22. Ferenci P.: J. Antimicrob. Chemother. 53, 15 (2004).
23. Myers R.P., Patel K., Pianko S., Poynard T., McHutchison J.G.: J. Viral. Hepat. 10, 16 (2003).
24. Hughes C.A., Shafran S.D.: Ann. Pharmacother. 40, 74 (2006).
25. Jara P., Hierro L., de la Vega A. et al.: Pediatr. Infect. Dis. J. 27, 142 (2008).
26. Kowala-Piaskowska A., Mozer-Lisewska I., Figlerowicz M., Służewski, W.: Pharmacoepidemiol. Drug Saf. 16, 1095 (2007).